Program - 5th Congress of Serbian Hematologists and 3rd Symposium of Hematology Nurses

PRELIMINARY PROGRAM FOR 06.10.2022.

6.10.2022	Satellite symposia
08:00-11:00 Registration of participants	Hall 1	Hall2
11:00-11:30	Medicopharmacia/Gilead Challenges in the therapy of invasive fungal infections in hematological patients Prof.dr Ana Vidovic Prof dr Ivana Urosevic	Farmix Moderator Prof dr Miodrag Vucic Challenges in diagnosis and treatment of acquired hemophilia Prof dr Predrag Miljic Dr Nebojsa Rajic
11:40-12:00	Octapharma Secondary immunodeficiencies in hematological patients Asst. Prof Darko Antić
12:10-12:55	MSD Infections in immunocompromised hematological patients Prof. dr Dragana Stamatovic Prof. dr Milena Todorović-Balint Prof. dr Ivana Urosevic
13:00-13:30	AstraZeneca Paroxysmal nocturnal hemoglobinuria - the importance of personalized therapy Challenges and therapeutic options Prof. Dr Ivana Urosevic Experiences of the Clinical Center of Vojvodina Prof. dr Aleksandar Savic Experiences of the Clinical Center of Serbia Prof. dr Andrija Bogdanovic Asst Prof. dr Mirjana Mitrovic	Medica Linea Pharm Venetoclax in CLL: significant efficacy, with limited duration of treatment MURANO study - 2 years of therapy for long-term remission in R/R CLL Prof. dr Predrag Djurdjevic CLL14 and study CLL13- 1 year of therapy for long-term remission in untreated CLL patients Prof. dr Ivana Milosevic
13:30-14:15	Pause
14:15-14:55	Pfizer The place of reserve antibiotics in pan-resistant infections in hematology Prof.dr Ivana Urosevic Prof. dr Sinisa Sevic Prof. dr Ana Vidovic Prof.dr Milena Todorovic Balint
15:00-15:30	Sandoz I symposium “ZIEXTENZO®- What is new about pegylated filgrastim in preventing febrile neutropenia? “ Asst Prof Olivera Markovic Prof.dr Predrag Djurdjevic	Pfizer Epidemiology, clinical picture and diagnosis of Gaucher's disease Prof.dr Nada Suvajdzic-Vukovic Modern therapeutic approach in the treatment of Gaucher disease Asst Prof Irena Cojbasic
15:30-16:00	Sandoz II symposium "RIXATHON, rituximab from the Sandoz company - experiences from clinical practice" Moderator Prof.dr Ivana Urosevic Ass.dr Danijela Agic Ass.dr Vojin Vukovic Ass.dr Zorica Cvetkovic
16:00-16:15	Pause
16:15-17:00	Amicus KYPROLIS®: STEP FORWARD IN PROTEASOME INHIBITION Multiple Myeloma in Serbia: Recommendations, Real-World Evidence, and Standard-of-Care Prof dr Jelena Bila "How I treat Multiple Myeloma? The role of Carfilzomib (Kyprolis®) Prof dr Meletios Dimopoulos
17:15-18:00	Plenary lecture - State of the Art- peripheral T cell lymphoma Prof.dr Luigi Zinzzani Asst Prof Darko Antic
19:30	Opening ceremony